The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Journal of Pharmacology

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2009.00580.xPMID 20105177PMCID PMC2828029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment.

  2009influential reference
• Differential Effects of M1 and 5-Hydroxytryptamine1A Receptors on Atypical Antipsychotic Drug-Induced Dopamine Efflux in the Medial Prefrontal Cortex

  2009cited by this paper
• Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats.

  2009cited by this paper
• Ginkgo biloba extract enhances male copulatory behavior and reduces serum prolactin levels in rats.

  2008cited by this paper
• A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline

  2008cited by this paper
• A top-down perspective on dopamine, motivation and memory.

  2008cited by this paper
• EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinsonism in mice: role of oxidative stress

  2008cited by this paper
• Guide to Receptors and Channels (GRAC), 3rd edition

  2008cited by this paper
• Turning over a new leaf

  2008cited by this paper
• In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.

  2008cited by this paper
• Chronic administration of a Ginkgo biloba leaf extract facilitates acquisition but not performance of a working memory task

  2008cited by this paper
• Converging effects of Ginkgo biloba extract at the level of transmitter release, NMDA and sodium currents and dendritic spikes.

  2008cited by this paper
• Ginkgo biloba for prevention of dementia: a randomized controlled trial.

  2008cited by this paper
• Structure‐activity analysis of ginkgolide binding in the glycine receptor pore

  2008cited by this paper
• Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers.

  2007cited by this paper
• Ginkgo Biloba Leave Extract: Biological, Medicinal, and Toxicological Effects

  2007cited by this paper
• Effects of Ginkgo biloba Extract EGb 761® on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial

  2007cited by this paper
• Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761).

  2007cited by this paper
• Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features

  2007cited by this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2007cited by this paper
• The GuidAge study

  2006cited by this paper
• The in vivo synaptic plasticity mechanism of EGb 761‐induced enhancement of spatial learning and memory in aged rats

  2006cited by this paper
• Dopaminergic enhancement of cognitive function.

  2006cited by this paper
• Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study

  2006cited by this paper
• Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences

  2005cited by this paper
• Noradrenaline and Dopamine Elevations in the Rat Prefrontal Cortex in Spatial Working Memory

  2005cited by this paper
• Presynaptic D1 Dopamine Receptors in Primate Prefrontal Cortex: Target-Specific Expression in the Glutamatergic Synapse

  2005cited by this paper
• Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors.

  2004cited by this paper
• The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus

  2004cited by this paper
• Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors

  2004cited by this paper
• Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation

  2004cited by this paper
• High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.

  2004influential reference
• The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.

  2004cited by this paper
• Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.

  2004cited by this paper
• Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.

  2003cited by this paper
• A Brief History of EGb 761® and its Therapeutic Uses

  2003cited by this paper
• Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.

  2003cited by this paper
• The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

  2003cited by this paper
• Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study.

  2003cited by this paper
• Neuroprotective effects of Ginkgo biloba extract

  2003cited by this paper
• Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

  2003cited by this paper
• Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels.

  2003influential reference
• Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications.

  2000influential reference
• In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761).

  2000influential reference
• D(1) receptors in prefrontal cells and circuits.

  2000cited by this paper
• Ginkgo Biloba Abolishes Aggression in Mice Lacking MAO A

  2000cited by this paper
• Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementia

  2000cited by this paper
• Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level.

  1999cited by this paper
• Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.

  1999influential reference
• Monitoring Chemistry of Brain Microenvironment: Biosensors, Microdialysis and Related Techniques

  1999cited by this paper
• D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans

  1998cited by this paper
• Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex

  1998cited by this paper
• Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi.

  1997cited by this paper
• Extracts of Ginkgo biloba leaves inhibit monoamine oxidase.

  1996influential reference
• Pyramidal neurone modulation: a therapeutic target for Alzheimer's disease.

  1996cited by this paper
• Cellular basis of working memory.

  1995cited by this paper
• Modulation of memory fields by dopamine Dl receptors in prefrontal cortex

  1995cited by this paper
• Decreased cerebral 5‐HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761)

  1994cited by this paper
• Neuropathological changes in Alzheimer disease.

  1994cited by this paper
• Chapter 29 Neuropathological changes in Alzheimer disease

  1994cited by this paper
• α2‐Adrenoceptor Changes During Cerebral Ageing. The Effect of Ginkgo biloba Extract

  1992cited by this paper
• In vivo characterisation of extracellular dopamine, GABA and acetylcholine from the dorsolateral striatum of awake freely moving rats by chronic microdialysis.

  1991cited by this paper
• Serotonin in Alzheimer‐type Dementia and Other Dementing Illnesses

  1990cited by this paper
• Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.

  1989cited by this paper
• [Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract].

  1986cited by this paper
• Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease.

  1986cited by this paper
• Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract

  1986cited by this paper
• Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.

  1986cited by this paper
• Effects of an extract of Ginkgo biloba on noradrenergic systems of rat cerebral cortex.

  1985cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

  1981cited by this paper
• Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey.

  1979cited by this paper

• Standardized Extract of Ginkgo biloba induced memory consolidation in female mice with hypofunction of vesicular acetylcholine transporter.

  2025cites this paper
• Pain reduction by hypericum scabrum extract in rats with long-term high-fat diet-induced obesity

  2025cites this paper
• Plant-Derived Nutraceuticals in Mental Health and Brain Function: Mechanisms of Action and Therapeutic Potential

  2025cites this paper
• Rapid structural transformation of ionizable lipid nanoparticles involving Omega-3 polyunsaturated fatty acids enhances antioxidant defense and mitochondrial proteins activity in pH-responsive drug delivery.

  2025cites this paper
• Standardized Ginkgo Biloba Extract (EGb 761) for Knee Osteoarthritis: A Narrative Review

  2025cites this paper
• Nutritional strategies against dementia in rural populations

  2025cites this paper
• Impact of Ginkgo biloba drug interactions on bleeding risk and coagulation profiles: A comprehensive analysis

  2025cites this paper
• Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review

  2025cites this paper
• The Potential of Selected Plants and Their Biologically Active Molecules in the Treatment of Depression and Anxiety Disorders

  2025cites this paper
• Anti-Neuroinflammatory Effects of Ginkgo biloba Extract EGb 761 in LPS-Activated BV2 Microglial Cells

  2024cites this paper
• EGb761 Trials for Mild-to-Moderate Dementia—What Have We Learned in the Past 18 years?

  2024cites this paper
• Vitex agnus castus Extract Ze 440: Diterpene and Triterpene’s Interactions with Dopamine D2 Receptor

  2024cites this paper
• Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease

  2024cites this paper
• Diabetes impairs male sexual behaviour: Ameliorative role of ethanol leaf extract of Alchornea cordifolia and its antihyperlipidemic activity

  2024cites this paper
• Comprehensive Exploration of the Neuroprotective Mechanisms of Ginkgo biloba Leaves in Treating Neurological Disorders.

  2024cites this paper
• Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review

  2024cites this paper
• Dopamine and Central Dopaminergic Circuitry in Neurodegenerative Diseases: Roles and Mechanisms of Action of Natural Phytochemicals

  2024cites this paper
• Iranian Traditional Medicine for Treatment of Attention Deficit Disorder with Hyperactivity in Children: A Systematic Review of Randomized Controlled Trials

  2024cites this paper
• Ginkgo biloba extracts improve choroidal circulation leading to suppression of myopia in mice

  2023cites this paper
• Tardive Dyskinesia Suppressed With Ginkgo Biloba.

  2023cites this paper
• Effects of Phoenix dactylifera against Streptozotocin-Aluminium Chloride Induced Alzheimer's Rats and Their In Silico Study

  2023cites this paper
• Opsin 5 mediates violet light-induced early growth response-1 expression in the mouse retina

  2023cites this paper
• Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus.

  2023cites this paper
• Naoxin’an capsules protect brain function and structure in patients with vascular cognitive impairment

  2023cites this paper
• A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

  2023cites this paper
• Promising botanical-derived monoamine oxidase (MAO) inhibitors: pharmacological aspects and structure-activity studies

  2022cites this paper
• Plant-derived nootropics and human cognition: A systematic review

  2022cites this paper
• Investigating the efficacy of Ginkgo biloba on the cognitive function of patients undergoing treatment with electric shock: a double-blind clinical trial

  2022cites this paper
• Green and Efficient Simultaneous Enrichment and Separation of Multiple Valuable Bioactive Compounds from Agricultural Waste Ginkgo biloba Exocarp Using a Two-Phase Deep Eutectic Solvent System

  2022cites this paper
• Natural product-based pharmacological studies for neurological disorders

  2022cites this paper
• Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia

  2022cites this paper
• Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review

  2022cites this paper
• Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing microglia-induced apoptosis

  2021cites this paper
• Ginkgo biloba

  2021cites this paper
• In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist

  2021cites this paper
• Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia

  2021cites this paper
• The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease

  2021cites this paper
• Neuroactive herbal agents for cognitive dysfunction

  2021cites this paper
• Pharmacologic treatments in preclinical tinnitus models with special focus on Ginkgo biloba leaf extract EGb 761®.

  2021cites this paper
• EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis

  2021cites this paper
• The Influence of Depression, Anxiety and Cognition on the Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Tinnitus and Dementia: A Mediation Analysis

  2021cites this paper
• Neuroregulatory role of ginkgolides

  2021cites this paper
• Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)

  2021cites this paper
• Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders

  2021cites this paper
• Endophytes from Gingko biloba: the current status

  2020cites this paper
• Electrophysiological, Behavioral and Molecular Study of Vitamin E and Ginkgo biloba in a Rat Model of Alzheimer’s Disease

  2020cites this paper
• Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus

  2020cites this paper
• Overview on Phyto-based Treatment for Anxiety

  2020cites this paper
• Ginkgo biloba modulates hippocampal BDNF expression in a rat model of chronic restraint stress-induced depression

  2020influential citation
• ADHD-Relevant Motor and Cognitive Effects of a Fixed-Dose Combination of Caffeine, Gingko Biloba and β-Phenethylamine (PEA)

  2020cites this paper
• Aqueous and ethanol extracts of Dracaena arborea (Wild) Link (Dracaenaceae) alleviate reproductive complications of diabetes mellitus in rats

  2019cites this paper
• Potential Treatment Strategies for the Treatment of Dementia With Chinese Medicinal Plants

  2019cites this paper
• Target Proteins in the Dorsal Hippocampal Formation Sustain the Memory-Enhancing and Neuroprotective Effects of Ginkgo biloba

  2019cites this paper
• Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®

  2019cites this paper
• Gingko biloba Extract (EGb) Inhibits Oxidative Stress in Neuro 2A Cells Overexpressing APPsw

  2019cites this paper
• Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.

  2019cites this paper
• The Importance of Natural Antioxidants in the Treatment of Spinal Cord Injury in Animal Models: An Overview

  2019cites this paper
• Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury

  2019cites this paper
• One water-soluble polysaccharide from Ginkgo biloba leaves with antidepressant activities via modulation of the gut microbiome.

  2019cites this paper
• Pathology, Prevention and Therapeutics of Neurodegenerative Disease

  2019cites this paper
• Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease

  2019cites this paper
• Ginkgo biloba L. (Ginkgoaceae) Leaf Extract Medications From Different Providers Exhibit Differential Functional Effects on Mouse Frontal Cortex Neuronal Networks

  2018cites this paper
• Anti-inflammatory effects of Ginkgo biloba extract against trimethyltin-induced hippocampal neuronal injury

  2018cites this paper
• Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells.

  2018cites this paper
• Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation

  2018cites this paper
• Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)

  2018cites this paper
• Investigation of the effect of Ginkgo biloba leaf extract on spatial memory impairment and hippocampal neuronal loss caused by diabetes induced by streptozotocin in rats

  2018cites this paper
• Effect of methanolic extract of Alchornea cordifolia leaves on the sexual behavior of senescent and sexually inexperienced rats

  2018cites this paper
• The effects of wild blueberry on the cognition and mood of 7-10 year old children

  2018cites this paper
• Diagnosis and Treatment of Cognitive Impairments in Attention Deficit Syndrome in Adults

  2018cites this paper
• Ginkgo biloba Extract (GbE) Stimulates the Hypothalamic Serotonergic System and Attenuates Obesity in Ovariectomized Rats

  2017cites this paper
• Ginkgo biloba extract EGb761 attenuates brain death-induced renal injury by inhibiting pro-inflammatory cytokines and the SAPK and JAK-STAT signalings

  2017cites this paper
• Neuroprotective role of Ginkgo biloba against cognitive deficits associated with Bisphenol A exposure: An animal model study

  2017cites this paper
• Ginkgo biloba special extract LI 1370 improves dual-task walking in patients with MCI: a randomised, double-blind, placebo-controlled exploratory study

  2017cites this paper
• Identification of ginkgolide targets in brain by photoaffinity labeling

  2017cites this paper
• [Diagnosis and treatment of cognitive impairment in adults with attention deficit hyperactivity disorder].

  2017cites this paper
• The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson's and Huntington's Diseases.

  2017cites this paper
• Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment – a randomized double‐blind placebo‐controlled trial

  2016cites this paper
• Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions

  2016cites this paper
• Effects of standardized Ginkgo biloba extract on the acquisition, retrieval and extinction of conditioned suppression: Evidence that short-term memory and long-term memory are differentially modulated.

  2016cites this paper
• Systematic review of the role of medicinal plants and derived components on reduction of cyclophosphamide-induced toxicity in male genital system

  2016cites this paper
• An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia

  2016cites this paper
• Therapeutic Value of Ginkgo biloba Extract EGb 761® in an Animal Model (Meriones unguiculatus) for Noise Trauma Induced Hearing Loss and Tinnitus

  2016cites this paper
• Effects of Ginkgo biloba Extract EGb 761, Donepezil and their Combination on Central Cholinergic Function in Aged Rats.

  2015cites this paper
• The Asthenic Symptom Complex in Patients with Emotional Burnout Syndrome

  2015cites this paper
• Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders.

  2015cites this paper
• Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease

  2015cites this paper
• Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy

  2015cites this paper
• Comparative pharmacokinetics of a proliposome formulation of Ginkgo biloba extract and Ginaton in rats by a sensitive ultra performance liquid chromatography–tandem mass spectrometry method

  2015cites this paper
• Non-Pharmacological Treatments for ADHD in Youth.

  2015cites this paper
• Dietary Supplements as Cognitive Enhancers: The Role of Flavonoid-Rich Foods and their Relevance in Age-Related Neurodegeneration

  2015cites this paper
• Ähnlich stark wirksam wie synthetische Stoffe und besser verträglich?

  2015cites this paper
• Rethinking Ginkgo biloba L.: Medicinal uses and conservation

  2015cites this paper
• The methanol-soluble fraction of Millettia macrophylla (Fabaceae) stem bark endowed with estrogenic properties has adverse effects on the male reproductive system of Wistar rats

  2015cites this paper
• Current perspectives of tinnitus and its therapeutic options

  2015cites this paper
• Protective Effects of Ginkgo biloba Extract EGb 761 against Noise Trauma-Induced Hearing Loss and Tinnitus Development

  2014influential citation
• Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials

  2014cites this paper
• Effects of Dracaena arborea (Dracaenaceae) on sexual dysfunction in 4 weeks hyperglycemic male rats.

  2014cites this paper
• Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis

  2014cites this paper
• DETERMINATION OF 5-HYDROXYINDOLE-3-ACETIC ACID, DIHYDROXYPHENYLACETIC ACID, AND HOMOVANILLIC ACID IN THE BRAINS OF FREELY MOVING RATS USING MICRODIALYSIS COUPLED WITH HPLC–ECD

  2014cites this paper